Details

Overview: Guidance document on submission information for biologic drugs (Division 4, Schedule D) - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Jan 2, 2026 · edition #6
Timestamp: 2026-01-02T06:49:16.024Z
Language: en
Original URL: https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/submission-information-biologic-drugs-division-4-schedule-d.html
Replay URL: https://replay.healtharchive.ca/job-6/20260102064916/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/submission-information-biologic-drugs-division-4-schedule-d.html#ha_snapshot=431863
ID: 431863
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots